Use of escitalopram during pregnancy: Navigating towards international guidelines and the real world

Clinical Drug Investigation

Volumn 28, Issue 11, 2008, Pages 735-739

  Gentile, Salvatore ^a  

^a ASL Salerno 1   (Italy)

Author keywords

Alprazolam, therapeutic use; Breast feeding; Escitalopram, therapeutic use; Panic disorder; Pregnancy

Indexed keywords

ALPRAZOLAM; ESCITALOPRAM;

ADULT; ARTICLE; CASE REPORT; DRUG MONITORING; FEMALE; HUMAN; INTERNATIONAL COOPERATION; MATERNAL WELFARE; PANIC; PRACTICE GUIDELINE; PREGNANCY; PREGNANT WOMAN; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; CITALOPRAM; FEMALE; FETUS; HUMANS; INFANT, NEWBORN; INTERNATIONAL COOPERATION; LACTATION; LIVE BIRTH; MALE; MATERNAL-FETAL EXCHANGE; PANIC DISORDER; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOTROPIC DRUGS; RISK ASSESSMENT; SEROTONIN UPTAKE INHIBITORS;

EID: 53549119422     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200828110-00006     Document Type: Article

References (37)

1. Altshuler LL, Cohen LS, Vitonis AF, et al. The Pregnancy Depression Scale (PDS): a screening tool for depression in pregnancy. Arch Womens Ment Health Epub. 2008 Jun 26
2. Acs N, Bánhidy F, Horváth-Puhó E, et al. Maternal panic disorder and congenital abnormalities: a population-based case-control study. Birth Defects Res A Clin Mol Teratol 2006; 76: 253-61
3. Warren SL, Racu C, Gregg V, et al. Maternal panic disorder: infant prematurity and low birth weight. J Anxiety Disord 2006; 20: 342-52
4. Banhidy F, Acs N, Puhó E, et al. Association between maternal panic disorders and pregnancy complications and delivery outcomes. Eur J Obstet Gynecol Reprod Biol 2006; 124: 47-52
5. Warren SL, Gunnar MR, Kagan J, et al. Maternal panic disorder: infant temperament, neurophysiology, and parenting behaviors. J Am Acad Child Adolesc Psychiatry 2003; 42: 814-25
6. Manassis K, Bradley S, Goldberg S, et al. Behavioural inhibition, attachment and anxiety in children of mothers with anxiety disorders. Can J Psychiatry 1995 Mar; 40 (2): 87-92
7. American Academy of Pediatrics. Use of psychoactive medications during pregnancy and possible effects on the fetus and newborn. Pediatrics 2000; 105: 880-7
8. American College of Obstetricians and Gynecologists. Use of psychotropic medications in pregnancy and lactation. Pract Bull 2008; 92: 1001-20
9. Gentile S. The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf 2005; 28: 135-52
10. Bradley EH, Webster TR, Schlesinger M, et al. Patterns of diffusion of evidence-based clinical programmes: a case study of the Hospital Elder Life Program. Qual Saf Health Care 2006; 15: 334-8
11. Diagnostic and statistical manual of mental disorders; text revision. Fourth edition. Washington, DC: American Psychiatric Association, 2000
12. Clayton AH. Symptoms related to the menstrual cycle: diagnosis, prevalence, and treatment. J Psychiatr Pract 2008; 14: 13-21
13. Sansone RA, Rytwinski D, Gaither GA. Borderline personality and psychotropic medication prescription in an outpatient psychiatry clinic. Compr Psychiatry 2003; 44: 454-8
14. Moja PL, Cusi C, Sterzi RR, et al. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev 2005; (3): CD002919
15. Andrade SE, Raebel MA, Brown J, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008; 198: 194.e1-5
16. Bakker MK, Kölling P, van den Berg PB, et al. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. Br J Clin Pharmacol 2008; 65: 600-6
17. Oberlander TF, Warburton W, Misri S, et al. Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Def Res B Dev Reprod Toxicol 2008; 83: 68-76
18. Einarson A, Pistelli A, DeSantis M, et al. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry 2008; 165: 749-52
19. Gentile S. SSRIs in pregnancy and lactation: emphasis on neurodevelopmental outcome. CNS Drugs 2005; 19: 623-33
20. Gentile S. Escitalopram use late in pregnancy and during breastfeeding. Ann Pharmacother 2006; 40: 1696-7
21. Suri R, Altshuler L, Hellemann G, et al. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry 2007; 164: 1206-13
22. Majewski S, Donnenfeld AE, Kuhlman K, et al. Second-trimester prenatal diagnosis of total arhinia. J Ultrasound Med 2007; 26: 391-5
23. Potts AL, Young KL, Carter BS, et al. Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram. J Perinatal 2007; 27: 120-2
24. Kallen BAJ, Otterblad Olausson P. Maternal use of selective serotoninergic reuptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 2007; 79: 301-8
25. Sit DK, Perel JM, Helsel JC, et al. Changes in antidepressant metabolism and dosing across pregnancy and early postpartum. J Clin Psychiatry 2008; 69: 652-8
26. Michelson D, Lydiard RB, Pollack MH, et al. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group. Am J Psychiatry 1998; 155: 1570-7
27. Barry M, Lester BM, Tronick EZ. History and description of the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics 2004; 113: 634-40
28. Moses-Kolko EL, Bogen D, Perel J, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005; 18: 2372-82
29. Lennestal R, Källén B. Delivery outcome in relation to maternal use of some recently introduced antidepressants. J Clin Psychopharmacol 2007; 27: 607-13
30. Eggermont E, Raveschot J, Deneve V, et al. The adverse influence of imipramine on the adaptation of the newborn infant to extrauterine life. Acta Paediatr Belg 1972; 26: 197-204
31. Gentile S. SRI-induced perinatal complications. Pediatr Drugs 2007; 9: 97-106
32. Laegreid L, Hagberg G, Lundberg A. The effects of benzodiazepines on the fetus and the newborn. Neuropediatrics 1992; 23: 18-23
33. Wikner BN, Stiller CO, Bergman U, et al. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol Drug Saf 2007; 16: 1203-10
34. Oberlander TF, Warburton W, Misri S, et al. Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study. Br J Psychiatry 2008; 192: 338-43
35. Roberge P, Marchand A, Reinharz D, et al. Cognitive-behavioral treatment for panic disorder with agoraphobia: a randomized, controlled trial and cost-effectiveness analysis. Behav Modif 2008; 32: 333-51
36. Gentile S. Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index. Drug Saf 2007; 30: 107-21
37. Gentile S, Rossi A, Bellantuono C. SSRIs during breastfeeding: spotlight on milk-to-plasma ratio. Arch Womens Ment Health 2007; 10: 39-51